Utah Medical Products UTMD Income Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $8.53M-14.3% | $8.72M-10.2% | $9.04M-1.2% | $9.81M-1.9% | $9.95M-4.3% | ||
| —— | $3.44M-17.5% | $3.78M-1.4% | $4.21M+0.1% | $4.36M+5.1% | ||
| $4.76M-15.0% | $5.28M-4.6% | $5.26M-1.1% | $5.6M-3.4% | $5.6M-10.5% | ||
| 55.8%-0.4pp | 60.6%+3.5pp | 58.2%+0.1pp | 57.1%-0.9pp | 56.2%-3.9pp | ||
| $154K+14.1% | $154K0.0% | $212K+75.2% | $167K-2.9% | $135K-47.1% | ||
| —— | $2.56M+14.9% | —— | $2.83M+23.6% | $2.26M-11.6% | ||
| —— | —— | $512.75K+7.9% | $512.75K+7.9% | $512.75K+7.9% | ||
| —— | —— | $1.97M+0.6% | $1.97M+0.6% | $1.97M+0.6% | ||
| $2.11M-12.1% | $2.72M+13.9% | —— | $2.99M+21.7% | $2.4M-14.8% | ||
| $2.65M-17.1% | $2.57M-18.6% | $2.44M-16.7% | $2.61M-21.9% | $3.2M-7.0% | ||
| 31.1%-1.1pp | 29.4%-3.1pp | 27%-5.0pp | 26.6%-6.8pp | 32.1%-0.9pp | ||
| —— | $0— | $0— | $0— | $0— | ||
| —— | $617K-12.5% | -$2.16M+19.8% | $698K-16.5% | $640K-17.2% | ||
| $3.29M-14.3% | $3.18M-17.5% | $3.11M-81.5% | $3.31M-20.8% | $3.84M-8.9% | ||
| —— | $578K-29.3% | $540K-81.6% | $678K+10.1% | $788K+4.0% | ||
| $2.69M-11.9% | $2.6M-14.4% | $2.57M-11.6% | $2.63M-26.2% | $3.05M-11.7% | ||
| 31.5%+0.9pp | 29.9%-1.5pp | 28.4%-3.3pp | 26.8%-8.8pp | 30.6%-2.6pp | ||
| $0.84-10.2% | $0.82-10.9% | $0.80-7.0% | $0.82-20.4% | $0.94-4.1% | ||
| $2.65M-17.1% | $2.57M-18.6% | $2.44M-16.7% | $2.61M-21.9% | $3.2M-7.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Utah Medical Products's revenue?
- Utah Medical Products (UTMD) generated $36.1M in revenue over the trailing twelve months, down 7.0% year over year.
- Is Utah Medical Products profitable?
- Utah Medical Products reported $10.5M in net income over the trailing twelve months, a 29.0% net margin.
- What are Utah Medical Products's profit margins?
- Gross margin is 57.9% and operating margin is 28.4%, with a 29.0% net margin.
- What is Utah Medical Products's earnings per share?
- Utah Medical Products's diluted EPS over the trailing twelve months is $3.28.
- Where does Utah Medical Products's income statement data come from?
- Every line is extracted from Utah Medical Products's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
